Patents by Inventor Robin DOODEMAN

Robin DOODEMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEK INHIBITORS AND THERAPEUTIC USES THEREOF
    Publication number: 20250270180
    Abstract: The present disclosure provides compounds, compositions containing such compounds, and methods of designing, developing, producing and preparing compounds represented by general Formula (I), including pharmaceutically acceptable salts thereof or a synthetic intermediate thereof: The compounds act as MEK inhibitors and are capable of displaying one or more beneficial therapeutic effects, including treating cancer.
    Type: Application
    Filed: May 1, 2025
    Publication date: August 28, 2025
    Inventors: Brett Matthew Hall, Bart Lieven Decorte, Peter John King, Ruben Leenders, Anita Wegert, Kevin Fowler, Sarah Kolitz, Robin Doodeman, Jarno Poelakker, Rutger Henk Adriaan Folmer
  • MEK inhibitors and therapeutic uses thereof
    Patent number: 12351566
    Abstract: The present disclosure provides compounds, compositions containing such compounds, and methods of designing, developing, producing and preparing compounds represented by general Formula (I), including pharmaceutically acceptable salts thereof or a synthetic intermediate thereof: The compounds act as MEK inhibitors and are capable of displaying one or more beneficial therapeutic effects, including treating cancer.
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: July 8, 2025
    Assignee: Immuneering Corporation
    Inventors: Brett Matthew Hall, Bart Lieven Decorte, Peter John King, Ruben Leenders, Anita Wegert, Kevin Fowler, Sarah Kolitz, Robin Doodeman, Jarno Poelakker, Rutger Henk Adriaan Folmer
  • MEK IMMUNE ONCOLOGY INHIBITORS AND THERAPEUTIC USES THEREOF
    Publication number: 20250179057
    Abstract: The present disclosure provides compounds, compositions containing such compounds, and methods of designing, developing, producing and preparing compounds represented by general Formula (III), including pharmaceutically acceptable salts thereof or a synthetic intermediate thereof: The compounds act as MEK inhibitors and are capable of displaying one or more beneficial therapeutic effects, including treating cancer.
    Type: Application
    Filed: January 5, 2023
    Publication date: June 5, 2025
    Inventors: Brett Matthew Hall, Bart Lieven DeCorte, Peter John King, Ruben Leenders, Anita Wegert, Kevin Fowler, Sarah Kolitz, Robin Doodeman, Jarno Poelakker, Rutger Henk Adriaan Folmer
  • MEK INHIBITORS AND THERAPEUTIC USES THEREOF
    Publication number: 20230119327
    Abstract: The present disclosure provides compounds, compositions containing such compounds, and methods of designing, developing, producing and preparing compounds represented by general Formula (I), including pharmaceutically acceptable salts thereof or a synthetic intermediate thereof: The compounds act as MEK inhibitors and are capable of displaying one or more beneficial therapeutic effects, including treating cancer.
    Type: Application
    Filed: January 7, 2021
    Publication date: April 20, 2023
    Inventors: Brett Matthew Hall, Bart Lieven Decorte, Peter John King, Ruben Leenders, Anita Wegert, Kevin Fowler, Sarah Kolitz, Robin Doodeman, Jarno Poelakker, Rutger Henk Adriaan Folmer
  • Substituted pyrimidine compounds
    Patent number: 10189854
    Abstract: The invention relates to novel substituted pyrimidine compounds of general formula (I) in which the chemical groupings, substituents, variables and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: January 29, 2019
    Assignee: GRUENENTHAL GMBH
    Inventors: Antonio Nardi, Florian Jakob, Ingo Konetzki, Tobias Craan, Christian Hesslinger, Robin Doodeman
  • Novel substituted pyrimidine compounds
    Publication number: 20170066776
    Abstract: The invention relates to novel substituted pyrimidine compounds of general formula (I) in which the chemical groupings, substituents, variables and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.
    Type: Application
    Filed: November 17, 2016
    Publication date: March 9, 2017
    Inventors: Antonio NARDI, Florian JAKOB, Ingo KONETZKI, Tobias CRAAN, Christian HESSLINGER, Robin DOODEMAN
  • Novel substituted pyrimidine compounds
    Publication number: 20160016937
    Abstract: The invention relates to novel substituted pyrimidine compounds of general formula (I) in which the chemical groupings, substituents, variables and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.
    Type: Application
    Filed: July 15, 2015
    Publication date: January 21, 2016
    Inventors: Antonio NARDI, Florian JAKOB, Ingo KONETZKI, Tobias CRAAN, Christian HESSLINGER, Robin DOODEMAN